NASDAQ$HSIC
Henry Schein Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Henry Schein reported record first-quarter financial results, driven by strong performance in dental and medical sales.
Henry Schein reported record first-quarter financial results with net sales of $3.2 billion, an increase of 8.7% compared to the first quarter of 2021. GAAP diluted EPS was $1.30, compared to $1.16 in the first quarter of 2021. The company affirmed its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91.
- Total first-quarter net sales reached $3.2 billion, up 8.7% compared to Q1 2021.
- GAAP diluted EPS was $1.30, compared to $1.16 in Q1 2021.
- Global Dental sales increased by 2.2% compared to the prior-year period.
- Global Medical sales increased by 18.3% compared to the comparable period last year.
Headline financials
Revenue & EPS history
Henry Schein · Revenue · Quarterly
$3.18B
Revenue by segment
Henry Schein · $3B total across 2 segments · Q1 2022
- Global Dental$1.83B+2.2%60.9%
- Global Medical$1.17B+18.0%39.1%
Forward guidance
Henry Schein affirms guidance for 2022 GAAP diluted EPS to be $4.75 to $4.91 and full year sales growth is expected to be approximately 5% to 8% over 2021.
Tailwinds
- 2022 GAAP diluted EPS attributable to Henry Schein, Inc. is expected to be $4.75 to $4.91.
- Reflects growth of 7% to 10% compared with 2021 GAAP diluted EPS of $4.45.
- Reflects growth of 5% to 9% compared with 2021 non-GAAP diluted EPS of $4.52.
- 2022 full year sales growth is expected to be approximately 5% to 8% over 2021.
- Guidance assumes that foreign currency exchange rates will remain generally consistent with current levels and end markets will remain stable.
Headwinds
- Sales growth primarily reflects the latest foreign exchange rates and a decrease in sales of COVID-19 test kits.
- Guidance does not include the impact of future share repurchases.
- Guidance does not include potential future acquisitions or restructuring expenses, if any.
- Guidance assumes that there are no material adverse market changes associated with COVID-19.
- Forward-looking statements are subject to risks and uncertainties.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-0.4%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.6%
Avg return
30 days after
45%
31 / 69 earnings
Positive
+11.1%
Q4 2021
Best reaction
-8.5%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.3% | -1.6% | +4.6% | |
| Q4 2025 | +5.8% | +2.3% | -8.5% | |
| Q3 2025 | +10.9% | +11.2% | +13.5% | |
| Q1 2025 | +2.0% | +5.1% | +7.8% | |
| Q4 2024 | -2.3% | -7.0% | -10.6% | |
| Q3 2024 | -3.2% | -6.0% | +0.2% | |
| Q2 2024 | -5.4% | -0.9% | +0.4% | |
| Q1 2024 | +6.2% | +7.0% | +0.1% | |
| Q4 2023 | -5.1% | -4.6% | -6.3% | |
| Q3 2023 | +7.5% | +7.3% | +15.5% | |
| Q2 2023 | -2.8% | -1.8% | -5.1% | |
| Q1 2023 | -4.5% | -4.2% | -6.1% | |
| Q4 2022 | -6.2% | -7.5% | -12.8% | |
| Q3 2022 | +1.8% | +6.2% | +21.2% | |
| Q2 2022 | -4.9% | -3.8% | -7.3% | |
| Q1 2022 | +7.4% | +6.6% | +5.6% | |
| Q4 2021 | +11.1% | +10.1% | +14.5% | |
| Q3 2021 | +3.0% | +4.5% | -6.7% | |
| Q2 2021 | -4.8% | -5.2% | -2.3% | |
| Q1 2021 | +6.6% | +8.9% | +5.3% | |
| Q4 2020 | -8.5% | -6.5% | -5.3% | |
| Q3 2020 | -5.0% | -3.0% | +4.6% | |
| Q2 2020 | -5.3% | -4.4% | -6.9% | |
| Q1 2020 | +0.4% | +2.9% | +20.6% | |
| Q4 2019 | -8.4% | -14.4% | -38.9% | |
| Q3 2019 | +4.4% | +4.8% | +5.2% | |
| Q2 2019 | -3.2% | -2.3% | -4.2% | |
| Q1 2019 | +8.6% | +8.9% | +8.6% | |
| Q4 2018 | -5.0% | -5.2% | -5.2% | |
| Q3 2018 | +3.1% | +0.8% | +3.3% | |
| Q2 2018 | -0.5% | -3.6% | +0.5% | |
| Q1 2018 | -6.1% | -4.4% | -6.7% | |
| Q4 2017 | -1.2% | -2.1% | -5.2% | |
| Q3 2017 | -8.5% | -13.6% | -13.0% | |
| Q2 2017 | -7.7% | -7.2% | -4.9% | |
| Q1 2017 | +0.6% | +0.3% | +5.2% | |
| Q4 2016 | +2.7% | +3.2% | +2.0% | |
| Q3 2016 | +4.6% | +6.2% | +1.7% | |
| Q2 2016 | -7.1% | -8.4% | -8.6% | |
| Q1 2016 | -2.5% | — | — | |
| Q4 2015 | +7.0% | — | — | |
| Q3 2015 | +1.1% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -0.4% | — | — | |
| Q4 2014 | +0.9% | — | — | |
| Q3 2014 | +5.4% | — | — | |
| Q2 2014 | -1.8% | — | — | |
| Q1 2014 | -1.7% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | -2.6% | — | — | |
| Q2 2013 | -0.3% | — | — | |
| Q1 2013 | +2.1% | — | — | |
| Q4 2012 | -2.2% | — | — | |
| Q3 2012 | -0.6% | — | — | |
| Q2 2012 | +1.8% | — | — | |
| Q1 2012 | +2.4% | — | — | |
| Q4 2011 | +3.4% | — | — | |
| Q3 2011 | -6.4% | — | — | |
| Q2 2011 | -2.3% | — | — | |
| Q1 2010 | -2.0% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | -3.9% | — | — | |
| Q1 2009 | -3.9% | — | — | |
| Q4 2008 | -3.9% | — | — | |
| Q3 2009 | -4.1% | — | — | |
| Q3 2010 | -4.1% | — | — | |
| Q2 2010 | +2.1% | — | — | |
| Q4 2009 | +2.1% | — | — | |
| Q2 2009 | +2.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro